Publication | Closed Access

1,10-Seco-Eudesmane sesquiterpenoids as a new type of anti-neuroinflammatory agents by suppressing TLR4/NF-κB/MAPK pathways

InflammationAnti-inflammatoryNeurobiology Of DiseaseNew TypeMedicineImmunologyPharmacologyPharmacological AgentPharmacotherapyNeurology1,10-Seco-eudesmane SesquiterpenoidsTlr4/nf-κb/mapk PathwaysNeuroimmunologyDrug DiscoveryNeuroinflammation